Total Payments
$20,736
2024 Payments
$3,472
Companies
38
Transactions
874
Medicare Patients
2,943
Medicare Billing
$282,616
Payment Breakdown by Category
Food & Beverage$16,217 (78.2%)
Other$4,300 (20.7%)
Gifts$143.04 (0.7%)
Travel$73.03 (0.4%)
Education$3.46 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,217 | 862 | 78.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,000 | 2 | 19.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 1.0% |
| Gift | $143.04 | 2 | 0.7% |
| Grant | $100.00 | 1 | 0.5% |
| Travel and Lodging | $73.03 | 1 | 0.4% |
| Education | $3.46 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,822 | 301 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $4,256 | 121 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $2,402 | 16 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,174 | 60 | $0 (2024) |
| Janssen Biotech, Inc. | $1,037 | 49 | $0 (2024) |
| PFIZER INC. | $939.34 | 56 | $0 (2024) |
| Gilead Sciences, Inc. | $893.48 | 30 | $0 (2024) |
| Celgene Corporation | $680.28 | 33 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $477.62 | 17 | $0 (2024) |
| Allergan Inc. | $422.16 | 18 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,472 | 154 | ABBVIE INC. ($938.97) |
| 2023 | $3,006 | 166 | ABBVIE INC. ($1,050) |
| 2022 | $2,310 | 138 | ABBVIE INC. ($795.42) |
| 2021 | $1,614 | 96 | AbbVie Inc. ($475.07) |
| 2020 | $635.63 | 34 | AbbVie Inc. ($306.03) |
| 2019 | $1,937 | 89 | AbbVie, Inc. ($432.39) |
| 2018 | $3,876 | 92 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($2,363) |
| 2017 | $3,886 | 105 | Valeant Pharmaceuticals North America LLC ($2,402) |
All Payment Transactions
874 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: GI | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Rare Disease | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Hepatology / Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 661 | 725 | $374,625 | $64,318 |
| 2022 | 12 | 754 | 850 | $394,372 | $77,267 |
| 2021 | 12 | 803 | 932 | $423,235 | $82,620 |
| 2020 | 13 | 725 | 809 | $302,300 | $58,411 |
Total Patients
2,943
Total Services
3,316
Medicare Billing
$282,616
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 190 | 250 | $56,250 | $23,286 | 41.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 101 | 101 | $131,300 | $20,726 | 15.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 83 | 83 | $66,400 | $5,240 | 7.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 65 | 66 | $66,000 | $4,695 | 7.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $14,025 | $2,574 | 18.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 20 | 20 | $16,000 | $2,274 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,400 | $1,814 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 27 | $4,050 | $1,758 | 43.4% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 69 | 69 | $10,350 | $1,646 | 15.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 76 | 78 | $5,850 | $305.02 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 228 | 313 | $70,425 | $28,708 | 40.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 90 | 90 | $117,000 | $18,457 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $17,875 | $8,136 | 45.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 85 | 88 | $70,400 | $6,145 | 8.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 57 | 57 | $57,000 | $3,904 | 6.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 58 | $8,700 | $3,838 | 44.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 18 | 21 | $16,800 | $2,317 | 13.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 11 | 11 | $10,285 | $2,086 | 20.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 14 | $13,090 | $1,796 | 13.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,522 | $1,047 | 41.5% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 17 | 17 | $2,550 | $436.73 | 17.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 101 | 103 | $7,725 | $397.45 | 5.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 213 | 317 | $71,325 | $31,192 | 43.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 108 | 108 | $140,400 | $22,615 | 16.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $15,400 | $7,718 | 50.1% |
About Dr. Eric Newton, MD
Dr. Eric Newton, MD is a Gastroenterology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952430019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Newton, MD has received a total of $20,736 in payments from pharmaceutical and medical device companies, with $3,472 received in 2024. These payments were reported across 874 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($16,217).
As a Medicare-enrolled provider, Newton has provided services to 2,943 Medicare beneficiaries, totaling 3,316 services with total Medicare billing of $282,616. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Providence, RI
- Active Since 03/05/2007
- Last Updated 09/09/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1952430019
Products in Payments
- XIFAXAN (Drug) $6,285
- RINVOQ (Biological) $1,114
- SKYRIZI (Biological) $1,010
- Humira (Biological) $922.03
- STELARA (Biological) $907.98
- XELJANZ (Drug) $835.38
- HUMIRA (Biological) $777.49
- ZEPOSIA (Drug) $664.93
- ZENPEP (Drug) $616.44
- LINZESS (Drug) $583.18
- ENTYVIO (Biological) $551.95
- OCALIVA (Drug) $477.62
- Entyvio (Biological) $393.60
- Trulance (Drug) $359.71
- TRULANCE (Drug) $327.32
- IBSRELA (Drug) $255.30
- VIBERZI (Drug) $250.98
- OMVOH (Drug) $219.89
- SUTAB (Drug) $199.96
- DUPIXENT (Biological) $182.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Providence
Thomas Sepe, Md, MD
Gastroenterology — Payments: $383,523
Gastroenterology $383,523
Paul Akerman, Md, MD
Gastroenterology — Payments: $163,964
Gastroenterology $163,964
Sean Fine, M.d, M.D
Gastroenterology — Payments: $63,236
Gastroenterology $63,236
Dr. Alan Epstein, M.d, M.D
Gastroenterology — Payments: $59,290
Gastroenterology $59,290
Samir Shah, M.d, M.D
Gastroenterology — Payments: $45,756
Gastroenterology $45,756
Lisa Mueller, Md, MD
Gastroenterology — Payments: $22,692
Gastroenterology $22,692